FDA push for fake Huntington’s brain surgery trial spurs ethical concerns

By Gerry Smith and Robert Langreth | Bloomberg

Katie Jackson desperately wants a new treatment for Huntington’s disease. Her husband died from the devastating brain disorder. And because the disease runs in families, her three children have a 50% chance of inheriting the condition. She’s pinned her hopes on a cutting-edge gene therapy from UniQure NV.

But Jackson says Huntington’s patients have no desire to meet a new demand from the US Food and Drug Administration: to enroll in...